glp 1 stimulation GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Frontiers | GLP-1 Suppresses Feeding
Description
There are currently two major players with a decisive head start in the obesity drug space: Eli Lilly (LLY) and Novo Nordisk (NVO)
Weight loss pills and a growing number of ways to buy the drugs could make them easier to access.
What Is Semaglutide GLP-1
The explosive demand for GLP-1 (glucagon-like peptide-1) receptor agonists, driven by their efficacy in treating obesity, has outpaced supply and created a dynamic market landscape
The United States is still deciding how exactly to approach GLP-1s
The weight loss pill also significantly improved heart health markers like cholesterol and blood pressure.
